Development of hepatitis B virus resistance for lamivudine in a Dutch cohort of HIV-HBV co-infected patients

被引：0
|
作者：
Wolters, LMM [1 ]
Niesters, HGM [1 ]
Brinkman, K [1 ]
Kroon, FP [1 ]
Richter, C [1 ]
Meenhorst, P [1 ]
de Man, RA [1 ]
机构：
[1] Univ Rotterdam Hosp, Rotterdam, Netherlands
来源：
JOURNAL OF HEPATOLOGY | 2001年 / 34卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：155 / 155
页数：1
相关论文
共 50 条
  • [21] Management of patients co-infected with hepatitis B virus and HIV
    Nunez, M
    Soriano, V
    LANCET INFECTIOUS DISEASES, 2005, 5 (06): : 374 - 382
  • [22] Hepatitis B virus drug resistance mutations in HIV/HBV co-infected children in Windhoek, Namibia
    Tchuem, Cynthia Raissa Tamandjou
    Brandt, Laura
    Nel, Etienne De la Rey
    Cotton, Mark Fredric
    Matthews, Philippa
    Kaindjee-Tjituka, Francina
    Preiser, Wolfgang
    Andersson, Monique Ingrid
    PLOS ONE, 2020, 15 (09):
  • [23] Mutations associated with lamivudine-resistance in therapy-naive hepatitis B virus (HBV) infected patients with and without HIV co-infection: Implications for antiretroviral therapy in HBV and HIV co-infected south African patients
    Selabe, S. Gloria
    Lukhwareni, Azwidowi
    Song, Ernest
    Leeuw, Yeegan G. M.
    Burnett, Rosemary J.
    Mphahlele, M. Jeffrey
    JOURNAL OF MEDICAL VIROLOGY, 2007, 79 (11) : 1650 - 1654
  • [24] Virological and biochemical evolution of HIV-HBV co-infected patients treated with tenofovir
    Vidiella, G.
    Rios, P.
    Biscayart, C.
    Castillo, S.
    Botas, A.
    Christin, M.
    Stamboulian, D.
    Rodriguez Iantorno, P.
    Vujacich, C.
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2010, 14 : E403 - E404
  • [25] Liver enzyme elevation after lamivudine withdrawal in HIV-hepatitis B virus co-infected patients: the Swiss HIV Cohort Study
    Bellini, C.
    Keiser, O.
    Chave, J-P
    Evison, J. M.
    Fehr, J.
    Kaiser, L.
    Weber, R.
    Vernazza, P.
    Bernasconi, E.
    Telenti, A.
    Cavassini, M.
    HIV MEDICINE, 2009, 10 (01) : 12 - 18
  • [26] Baseline characteristics of HIV & hepatitis B virus (HIV/HBV) co-infected patients from Kolkata, India
    Sarkar, Jayeeta
    Saha, Debraj
    Bandyopadhyay, Bhaswati
    Saha, Bibhuti
    Kedia, Deepika
    Mazumder, D. N. Guha
    Chakravarty, Runu
    Guha, Subhasish Kamal
    INDIAN JOURNAL OF MEDICAL RESEARCH, 2016, 143 : 636 - 642
  • [27] The risk of adefovir monotherapy in human immunodeficiency virus (HIV) and hepatitis B virus (HBV) co-infected patients
    Gelinck, LBS
    Claas, ECJ
    Kroon, FP
    JOURNAL OF HEPATOLOGY, 2005, 43 (02) : 360 - 361
  • [28] Use of hepatitis B surface and "e" antigen quantification during extensive treatment with tenofovir in patients co-infected with HIV-HBV
    Boyd, Anders
    Maylin, Sarah
    Gozlan, Joel
    Delaugerre, Constance
    Simon, Francois
    Girard, Pierre-Marie
    Lacombe, Karine
    LIVER INTERNATIONAL, 2015, 35 (03) : 795 - 804
  • [29] Hepatitis B virus (HBV) response to therapy with lamivudine (LAM) and tenofovir (TFV) in HBV/HIv co-infected patients: Impact of genotype and treatment regimen.
    Jain, MK
    Comanor, L
    White, C
    Kipnis, P
    Elkin, C
    Leung, K
    Cantu, V
    Morgan, T
    Keiser, P
    Lee, WM
    HEPATOLOGY, 2004, 40 (04) : 673A - 673A
  • [30] Longitudinal evaluation of hepatitis B, C and/or D viremia in HIV-HBV co-infected patients: Virological interactions and effects of treatment
    Boyd, A.
    Lacombe, K.
    Serfaty, L.
    Miailhes, P.
    Gozlan, J.
    Bonnard, P.
    Molina, J. M.
    Lascoux-Combe, C.
    Desvarieux, M.
    Girard, R. M.
    JOURNAL OF HEPATOLOGY, 2008, 48 : S246 - S246
12345